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PURPOSE. To test the hypothesis that genes known to cause clinical syndromes featuring
myopia also harbor polymorphisms contributing to nonsyndromic refractive errors.
METHODS. Clinical phenotypes and syndromes that have refractive errors as a recognized
feature were identified using the Online Mendelian Inheritance in Man (OMIM) database. One
hundred fifty-four unique causative genes were identified, of which 119 were specifically
linked with myopia and 114 represented syndromic myopia (i.e., myopia and at least one
other clinical feature). Myopia was the only refractive error listed for 98 genes and hyperopia
and the only refractive error noted for 28 genes, with the remaining 28 genes linked to
phenotypes with multiple forms of refractive error. Pathway analysis was carried out to find
biological processes overrepresented within these sets of genes. Genetic variants located
within 50 kb of the 119 myopia-related genes were evaluated for involvement in refractive
error by analysis of summary statistics from genome-wide association studies (GWAS)
conducted by the CREAM Consortium and 23andMe, using both single-marker and gene-based
tests.
RESULTS. Pathway analysis identified several biological processes already implicated in
refractive error development through prior GWAS analyses and animal studies, including
extracellular matrix remodeling, focal adhesion, and axon guidance, supporting the research
hypothesis. Novel pathways also implicated in myopia development included mannosylation,
glycosylation, lens development, gliogenesis, and Schwann cell differentiation. Hyperopia was
found to be linked to a different pattern of biological processes, mostly related to
organogenesis. Comparison with GWAS findings further confirmed that syndromic myopia
genes were enriched for genetic variants that influence refractive errors in the general
population. Gene-based analyses implicated 21 novel candidate myopia genes (ADAMTS18,
ADAMTS2, ADAMTSL4, AGK, ALDH18A1, ASXL1, COL4A1, COL9A2, ERBB3, FBN1, GJA1,
GNPTG, IFIH1, KIF11, LTBP2, OCA2, POLR3B, POMT1, PTPN11, TFAP2A, ZNF469).
CONCLUSIONS. Common genetic variants within or nearby genes that cause syndromic myopia
are enriched for variants that cause nonsyndromic, common myopia. Analysis of syndromic
forms of refractive errors can provide new insights into the etiology of myopia and additional
potential targets for therapeutic interventions.
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There is growing recognition that myopia represents asignificant public health issue.1–3 In relation to developing
preventive public health strategies and potential treatments,
this makes understanding the etiology of myopia all the more
important. There has been a long-running debate about
whether myopia is predominantly genetic or environmental.4,5
The rising prevalence of myopia over recent decades has led to
recognition that environmental effects must play an important
role. Yet there remains strong evidence that genetic factors also
make a significant contribution. The first clear evidence for a
genetic role in myopia came from twin studies, with identical
(monozygotic) twins showing a higher similarity (concordance)
in refractive error than nonidentical (dizygotic) twins.6,7 Such
studies have estimated heritability for myopia to be as high as
91%. Observed associations between parent refraction and that
of their children may also have a genetic contribution.8–11
Conventional genetic linkage analysis studies revealed a
number of potential loci for myopia-related genes, but the
causative genes have mostly proved elusive.12–14
More recently, genome-wide association studies (GWAS)
have attempted to identify genes associated with the risk of
developing myopia. Early GWAS studies that focused on a
handful of plausible candidate genes reported association
between common gene variants and myopia or high myopia,
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using sample sizes of a few hundred participants; however, the
results showed limited replication in later studies.14,15 In
contrast, a move to sample sizes in the thousands, coupled
with a much more systematic examination of common genetic
variants across the whole genome, has proved more successful,
with more than 100 gene loci identified and excellent
concordance between studies.16–19 However, these loci
together explain only a small percentage of the observed
variation in refractive error (e.g., 2.3% in a study of children20
and 10% in a sample of adults17). The difference between the
heritability estimates from twin and GWAS studies has been
described as the ‘‘missing heritability’’ or ‘‘heritability gap’’ in
myopia.2,21 This difference indicates either that twin studies
have greatly overestimated the genetic contribution to
refractive error, or a large number of refractive error–related
genes have yet to be identified.
To date, one potential source of genetic variation in myopia
has largely been overlooked, namely syndromic myopia, that is,
myopia associated with at least one other medical condition.
Many medical syndromes are genetic in origin, with clearly
defined Mendelian inheritance patterns and positively identi-
fied genes. Some of the better-known forms of syndromic
myopia are linked with genes that have a plausible role in
myopia pathogenesis. For example Stickler’s syndrome is most
commonly associated with defects in the gene for collagen type
II alpha-1 (COL2A1), which is expressed in the sclera, a
structure that displays significant alterations in myopia.22,23
What has been lacking to date is a comprehensive analysis of
the genetic basis of syndromic myopia and its potential broader
relevance to refractive error development.
The primary aim of the present study was to examine the
hypothesis that a proportion of human myopia results from
polymorphisms in genes known to cause myopic syndromes.
To achieve this aim, we compared the locations of identifiable
syndromic myopia genes with data from two large GWAS
studies that examined refractive errors and myopia (specifical-
ly, those carried out by CREAM17 and 23andMe16). Our second
aim was to determine whether any specific biological
processes that might be associated with the genetic control
of refractive error could be identified from analyzing the
functions of genes linked to syndromic myopia.
METHODS
Identification of Genes Causing Syndromic Forms
of Myopia
We identified clinical phenotypes that have refractive errors as
a recognized feature using the Online Mendelian Inheritance in
Man database (OMIM, Johns Hopkins University, Baltimore,
MD, USA). OMIM is an expert-curated, comprehensive database
of human genetic disorders and provides information about
both the clinical features and specific causative genes where
identified.
The entire OMIM database was downloaded in text format
for off-line analysis following registration of this project with
Johns Hopkins University (http://www.omim.org; in the public
domain). Purpose-written software (predominantly written in
AWK, a Unix scripting language) was used to process this text
file to extract clinical syndromes that included any form of
refractive error within the clinical features. The extraction of
syndromes with refractive errors was performed on the basis of
the phenotypic descriptors within OMIM. The latter are based
on a clinical categorization from the wide variety of the cited
papers for each condition, and therefore no consistent or
specific dioptric thresholds could be derived. The list of terms
used is shown in Table 1. The resulting set of phenotypic
entries was then reviewed to ensure the reliability of the
automated extraction process.
Two additional OMIM database files (morbidmap and
mim2gene.txt) were then used to determine if the phenotypes
were associated with a specific gene and to extract the relevant
NCBI Gene ID, Ensembl Gene ID, and the HGNC Approved
Gene Symbol. The final dataset of OMIM-derived ametropia
syndromes included OMIM entry number, clinical synopsis,
type of refractive error, cytogenetic locus, Ensembl Gene ID,
and HGNC (HUGO Gene Nomenclature Committee) nomen-
clature. All gene names referred to in this paper are the HGNC
descriptors.
Pathway Analysis: PANTHER, DAVID, REACTOME
Three different pathway analysis programs were used to search
for pathways enriched for genes identified from the OMIM
database. These were PANTHER (Protein Annotation Through
Evolutionary Relationships, http://www.pantherdb.org/ [in the
public domain], Version 11.0, released July 15, 2016),24 DAVID
(Database for Annotation, Visualization and Integrated Discov-
ery, Version 6.7, released January 27, 2010),25 and REACTOME
Version 54 (release date September 30, 2015).26 The PANTHER
Overrepresentation Test (release 20160715) was conducted
using the GO Biological Process Ontology database released
August 22, 2016, for human genes. Graphical representations
of functional relationships were created using GOplot.27
SNP-Based Comparison With CREAM GWAS Meta-
Analysis for Refractive Error
We tested whether naturally occurring, common variants in
the genes identified from the OMIM database were either more
often or more strongly associated with refractive error than
expected by chance. To do this, we took advantage of the
meta-analysis of refractive error GWAS studies carried out by
the CREAM Consortium.17 This CREAM GWAS meta-analysis
included 37,382 individuals from 27 European studies and
8376 from 5 Asian studies. Our analysis was restricted to GWAS
summary statistics for participants of European ancestry.
The CREAM study GWAS summary statistics provided a P
value quantifying the association with refractive error for
approximately 2.5 million autosomal genetic variants with a
minor allele frequency (MAF) > 0.01 from phase 2 of the
HapMap project.28 To identify single nucleotide polymor-
phisms (SNPs) in the vicinity of the genes identified by the
OMIM search, the transcription start and stop sites of each of
the 107 autosomal OMIM-derived myopia genes were retrieved
and converted to genome build GRCh37 (hg19) coordinates.
Twelve of the OMIM syndromic myopia genes were on
chromosome X, which was not included in the CREAM GWAS
TABLE 1. Search Terms Used to Detect Refractive Error Within OMIM
Entries
General Terms Astigmatism Myopia Hyperopia
Refractive error Astigmatism Myopia Hyperopia
Ametropia Astigmatic Myopic Hyperopic
Ametropic Short-sighted Hypermetropia
Short-sighted Hypermetropic
Short-sighted Long-sighted
Nearsighted Long-sighted
Nearsighted Long-sighted
Nearsighted Far-sighted
Far-sighted
Far-sighted
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meta-analysis; hence these X-linked genes could not be
included in CREAM comparison analysis.
After updating the CREAM GWAS results to GRCh37
coordinates, CREAM SNPs positioned within 650 kb of the
107 OMIM genes were selected, resulting in a list of 24,554
SNPs (note that the 50-kb flanking regions were included, since
the majority of GWAS loci discovered to date are located in
regulatory regions outside the coding region of genes29). Under
the null hypothesis that SNPs in OMIM selected genes were
neither more often nor more strongly associated with
refractive error than chance level, 5% of the 24,554 SNPs
(i.e., 1228) would be expected to attain a nominal level of
statistical significance (P < 0.05). Similarly, under the null
hypothesis, only a single SNP within the OMIM gene regions
would be expected to reach an ‘‘experiment-wise’’ level of
statistical significance of P ¼ 4.4E-05 (i.e., 1/24,554).
VEGAS: Gene-Based Comparison With CREAM
GWAS Meta-Analysis for Refractive Error
We used VEGAS (Versatile Gene-Based Association Study)30,31
to carry out a gene-based analysis of whether naturally
occurring, common variants in the genes identified from the
OMIM database were either more often or more strongly
associated with refractive error than expected by chance. The
same set of 24,554 SNPs within 650 kb of the 107 autosomal
OMIM genes selected from the CREAM GWAS meta-analysis
file, as described above, was submitted for analysis. VEGAS
reported results for all 107 of these genes (B3GLCT and P3H2
were listed in VEGAS as B3GALTL and LEPREL1, respectively).
SNP-Based Comparison With 23andMe GWAS for
Age of Onset of Myopia
A second, independent GWAS dataset was used to test whether
naturally occurring, common variants in the genes identified
from the OMIM database were either more often or more
strongly associated with refractive error than expected by
chance. The 23andMe company reported details of all 6141
genetic variants with P < 1E-04 from a GWAS using age of
onset of myopia16 to assess approximately 7 million genetic
variants (including variants on the X chromosome) in 45,000
participants of European ancestry. 23andMe imputed geno-
types in their participants with the MaCH/minimac program,
using the August 2010 release of the 1000 Genomes project as
the reference panel. We downloaded the 04/08/2010 European
reference panel data from the MaCH Web site (1000G.
EUR.20100804.tgz), which listed a total of N ¼ 11,914,767
variants. Of these 11.9 M variants, 87,598 were within 650 kb
of the 119 OMIM myopia genes. (Note that 23andMe used only
~7.0 M for their GWAS, having excluded from the set of 11.9 M
variants those with MAF < 0.005 and those that were poorly
imputed; therefore our use of the full list of 87,598 variants is
an overestimate of the true number of variants within the
OMIM gene regions assessed by 23andMe and will be
conservative). Under the null hypothesis of variants in OMIM
syndromic myopia genes not being either more often or more
strongly associated with age of onset of myopia than chance
level, we would expect 0.01% of the 87,598 variants (i.e.,
87,598/104 ¼ 9 variants) to attain P < 1.0E-04. Similarly, under
the null hypothesis, only a single SNP within the OMIM gene
regions would be expected to reach an experiment-wise level
of statistical significance of P ¼ 1.1E-05 (i.e., 1/87,598).
Statistical Analysis
Pathway overrepresentation was tested using the methods
implemented in PANTHER.32 A 1-sided binomial test was used
to evaluate whether the number of genetic variants reaching a
specified P value exceeded the number expected by chance,
using the R statistics package (RStudio Team [2015], RStudio:
Integrated Development for R, Boston, MA, USA).
RESULTS
A total of 219 clinical entities were identified within the OMIM
database as conditions featuring ametropia, and in 167 cases at
least one causative gene had been identified at the time of
analysis. Of these 167 genetically defined, ametropia-featuring
phenotypes, 162 were syndromic forms of refractive error,
with at least one other phenotypic feature, and 5 were known
Mendelian forms of high myopia. Myopia was the most
commonly listed refractive error (n ¼ 130), followed by
hyperopia (n¼ 43) and astigmatism (n¼ 23). Myopia was the
only type of refractive error described in 107 phenotypes. In
23 phenotypes, myopia was listed along with one or more
other types of refractive error. Overall, 154 unique genes
linked to various types of refractive error were identified
within this group of conditions. The phenotypic subset
associated with myopia (n ¼ 130) was found to represent a
set of 119 unique genes since 7 genes (COL2A1, COL11A1,
FBN1, LTBP2, POMT1, POMT2, POMGNT1) had two or more
associated phenotypes, leading to 11 duplicates. Hyperopia
was associated with 42 unique syndromic genes, and
astigmatism with 23 unique syndromic genes. Of the 119
myopia-associated genes, 107 were autosomal and 12 were on
the X chromosome.
A comparison of the chromosomal locations of the
complete set of 154 refractive error–associated genes with
the genes identified in the CREAM Consortium GWAS
analysis17 is shown in Figure 1. The complete list of
ametropia-associated genes identified within OMIM is given
in Supplementary Table S1.
Pathway Analysis
The biological processes associated with the 154 OMIM genes
linked to refractive errors were examined using the PANTHER
Overrepresentation Test, with Bonferroni correction for
multiple tests. This approach estimates both the overrepre-
sentation of a specific category of genes and the associated P
value. For the complete group of ametropia genes, a wide
range of biological processes was identified, as shown in Table
2. This table lists the identified biological process, the observed
number of genes associated with that process, the expected
number of such genes, the enrichment ratio, and the associated
corrected P value. It includes all biological processes that were
found to be statistically significant and where the level of gene
overrepresentation was at least a factor of 10.
A similar analysis for genes specifically associated with
myopia (rather than any type of ametropia) also revealed a
wide range of biological processes (see Table 3). Several of
these processes are highly plausible candidates for a role in the
pathogenesis of myopia, such as collagen organization and
metabolism, while others have not previously been associated
with myopia development, such as protein mannosylation,
glycosylation, and Schwann cell differentiation.
There is considerable overlap between the overrepresented
biological processes found in myopia-related genes and the
broader group of ametropia-related genes, as might be
expected since myopic syndromes are the largest subgroup.
Nevertheless, several processes either are unique to the
myopic syndromes, or show greater overrepresentation when
compared to the ametropic group. The four processes that are
significantly overrepresented in myopia but not in the
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ametropia group are protein O-linked mannosylation (GO
process: 0035269), collagen fibril organization (GO process:
0030199), lens development in camera-type eye (GO process:
0002088), and gliogenesis (GO process: 0042063). Thirteen
processes are highly overrepresented (>10-fold) within the
myopic syndromes to a greater degree than is observed within
the ametropic syndromic genes: protein O-linked glycosylation
(GO process: 0006493), Schwann cell differentiation (GO
process: 0014037), collagen metabolism processes (GO
processes: 0030574 and 0032963), visual processing (GO
processes: 0009584, 0007601, 0050953), extracellular matrix
organization and structure (GO processes: 0030198 and
0043062), and nonspecific metabolic processes (GO process-
es: 0044243, 0044259, 0044236). Figure 2 shows the
individual myopia-related genes associated with these overrep-
resented biological processes and their links to those
processes. As shown, several genes are linked to more than
one biological process.
A different pattern of biological processes was identified in
syndromes associated with hyperopia. There were just four
processes showing a greater than 10-fold overrepresentation (P
< 0.001 for each process) over that expected from an equally
random sample of human genes: sensory organ morphogene-
sis, camera-type eye development, eye development, and
sensory organ development. All four processes were also
identified in myopic and ametropic syndromes, but with a
lower level of overrepresentation. For syndromes that had
astigmatism as a feature there were 23 unique genes, but no
significant enrichment was found using the PANTHER analysis.
An analysis using DAVID identified enrichment of genes
involved in extracellular matrix (ECM) receptor interaction (P
¼ 5.4E-03), as well as those involving O-mannosyl glycan
biosynthesis (P ¼ 8.9E-03) and focal adhesion (P ¼ 3.5E-02).
Finally, pathway analysis using REACTOME identified enrich-
ment for signaling by PDGF (platelet-derived growth factor; P¼
6.3E-06), axon guidance (P¼ 2.8E-04), and integrin cell surface
interactions (P ¼ 2.1E-03).
SNP-Based Comparison With CREAM GWAS Meta-
Analysis for Refractive Error
Figure 3 shows the level of association between genotype and
refractive error observed in the GWAS meta-analysis of 37,382
European participants, carried out by the CREAM Consortium
for the 24,554 SNPs lying within 50 kb of the 107 autosomal
OMIM syndromic myopia genes. Of these 24,554 SNPs, 1717
TABLE 2. Biological Processes Overrepresented Among 154 OMIM Genes Known to Cause Syndromic Ametropia (PANTHER Analysis)
GO Biological Process Observed Expected Enrichment P Value
Schwann cell differentiation 5 0.23 21.42 3.65E-02
Detection of visible light 6 0.31 19.13 7.55E-03
Body morphogenesis 6 0.32 18.69 8.62E-03
Collagen catabolic process 8 0.47 17.13 2.56E-04
Collagen metabolic process 9 0.54 16.67 4.36E-05
Visual perception 25 1.54 16.24 9.18E-19
Sensory perception of light stimulus 25 1.56 16.01 1.28E-18
Multicellular organismal macromolecule metabolic process 9 0.58 15.62 7.61E-05
Eye morphogenesis 16 1.03 15.55 1.14E-10
Multicellular organism catabolic process 8 0.52 15.44 5.63E-04
Multicellular organism metabolic process 10 0.68 14.74 1.93E-05
Detection of light stimulus 6 0.42 14.18 4.16E-02
Eye development 32 2.44 13.13 3.43E-22
Sensory organ morphogenesis 22 1.81 12.16 1.55E-13
Camera-type eye development 25 2.12 11.82 1.63E-15
Proteoglycan metabolic process 7 0.62 11.29 2.96E-02
Retina development in camera-type eye 11 0.98 11.17 5.17E-05
Protein O-linked glycosylation 8 0.74 10.86 7.85E-03
Camera-type eye morphogenesis 8 0.76 10.54 9.74E-03
Sensory organ development 37 3.69 10.02 3.17E-22
FIGURE 1. Chromosomal locations of all genes associated with syndromic ametropia in the OMIM database and the genes identified in the CREAM
Consortium GWAS analysis.
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exceeded the nominal level of statistical significance (P <
0.05), and 15 exceeded the experiment-wise significance
threshold. These numbers are far higher than expected by
chance (P < 2.2E-16 and P ¼ 3.0E-13, respectively; binomial
test), arguing strongly against the null hypothesis that the
OMIM syndromic genes were not enriched for variants
associated with refractive error. The QQ plot (Fig. 3B) also
suggests that SNPs in the OMIM gene regions are consistently
more strongly associated with refractive error than expected
by chance (i.e., outside the 95% confidence intervals). A
Manhattan plot (Fig. 3A) shows these strongly associated SNPs
to be distributed across many genomic regions rather than all
being clustered within one or two OMIM gene regions.
Gene-Based Comparison With CREAM GWAS Meta-
Analysis for Refractive Error
The above SNP-based comparison between genes identified by
the OMIM search and the CREAM Consortium GWAS meta-
analysis was carried out under the assumption that SNP
associations were independent of each other. While this
assumption is reasonable for distantly spaced SNPs, it will be
violated for SNPs in the same region, since alleles are often
inherited together on the same parental chromosome—a
phenomenon known as linkage disequilibrium (LD). VEGAS
analysis takes account of LD between SNPs in order to provide
a gene-based assessment of the evidence for greater levels of
association than expected by chance.
For the 24,554 SNPs examined above, VEGAS reported
results for all 107 autosomal OMIM syndromic myopia genes.
By chance, that is, under the null hypothesis that the OMIM
genes were not enriched for SNPs associated with refractive
error, approximately 5% of the 107 genes (i.e., 5 genes) would
be expected to reach a nominal level of statistical significance.
In contrast, VEGAS analysis identified 17 genes that also
exceeded this threshold, but this was unlikely to have occurred
by chance (P ¼ 2.6E-05; binomial test). The OMIM-derived
syndromic myopia genes that had greater than expected levels
of enrichment for refractive error-associated SNPs in the
VEGAS analysis are shown in Table 4. A QQ plot confirmed
that the distribution of P values from the VEGAS analysis was
enriched for strongly associated genes compared to that
expected by chance (Fig. 4).
Kiefer et al.16 from 23andMe carried out a GWAS for age of
onset of myopia, reporting 6141 genetic variants (SNPs and
short insertions/deletions) that exceeded P < 1.0E-04 for
association with myopia in their sample of 45,000 participants
of European ancestry. However, we did not have information
regarding which genetic variants were tested by Kiefer et al.
and therefore we could not determine the precise number of
variants within 50 kb of the 119 OMIM syndromic myopia
genes. We estimated the maximum possible number of variants
that could have been within 50 kb of the 119 OMIM syndromic
myopia genes to be 87,598 (see Methods section for details). By
chance, 0.01% of these 87,598 variants, that is, 9 variants, are
expected to reach P < 1.0E-04. In fact, many more than this, 31
variants, exceeded this threshold (P < 4.3E-09; binomial test).
These 31 variants were clustered near five of the OMIM
syndromic myopia genes (Table 5). However, none of the 31
variants exceeded the experiment-wise threshold of P < 1.1E-
05 for the 23andMe analysis. There was no overlap between
the 5 OMIM-derived genes showing enrichment in the
23andMe GWAS for age at onset of myopia (Table 5) and the
17 genes showing enrichment in the VEGAS analysis of the
CREAM GWAS for refractive error (Table 4).
DISCUSSION
The genomic analysis of syndromic myopia described in this
paper has identified a number of additional genes of potential
relevance for myopia development in the general populations
on which the CREAM and 23andMe studies were based. Of the
22 genes listed in Tables 4 and 5, only 1 (SLC39A5) is
associated with one of the designated myopia (MYP) loci
within OMIM, specifically the MYP24 locus. At the time of
writing only four other MYP loci have had putative genes
identified, these being MYP6 (gene: SCO2), MYP21 (gene:
ZNF644), MYP22 (gene: PRIMPOL), and MYP23 (gene:
LRPAP1). While none of these genes showed a significant
association with refractive error in the VEGAS analysis of the
CREAM GWAS dataset, ZNF644 at the MYP21 locus is a
member of the Kru¨ppel C2H2-type zinc-finger protein family,
TABLE 3. Biological Processes Overrepresented Among 119 OMIM Genes Known to Cause Syndromic Myopia (PANTHER Analysis)
GO Biological Process Observed Expected Enrichment P Value
Protein O-linked mannosylation 4 0.09 44.06 2.04E-02
Schwann cell differentiation 5 0.18 27.54 1.07E-02
Collagen fibril organization 5 0.22 22.59 2.78E-02
Collagen catabolic process 8 0.36 22.03 3.56E-05
Collagen metabolic process 9 0.42 21.43 4.71E-06
Detection of visible light 5 0.24 20.49 4.44E-02
Multicellular organismal macromolecule metabolic process 9 0.45 20.08 8.29E-06
Body morphogenesis 5 0.25 20.03 4.96E-02
Multicellular organism catabolic process 8 0.4 19.86 7.90E-05
Visual perception 21 1.2 17.54 4.17E-16
Sensory perception of light stimulus 21 1.21 17.29 5.53E-16
Multicellular organism metabolic process 9 0.53 17.06 3.37E-05
Lens development in camera-type eye 6 0.39 15.55 2.40E-02
Protein O-linked glycosylation 8 0.57 13.96 1.15E-03
Eye morphogenesis 11 0.8 13.75 5.60E-06
Eye development 23 1.9 12.14 1.81E-14
Camera-type eye development 18 1.65 10.94 6.81E-10
Extracellular matrix organization 19 1.75 10.84 1.55E-10
Extracellular structure organization 19 1.76 10.8 1.64E-10
Sensory organ morphogenesis 15 1.41 10.66 1.31E-07
Retina development in camera-type eye 8 0.77 10.44 9.99E-03
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and another member of this family, ZNF469, causes type 1
brittle cornea syndrome, which features blue sclera and
myopia. Thus, the Kru¨ppel C2H2-type zinc-finger protein
family is of potential interest in terms of refractive error
development. There is a notable lack of concordance in the
VEGAS gene-based test results obtained using the CREAM
GWAS summary statistics versus the 23andMe GWAS summary
statistics. We speculate that this disparity is due to a
combination of (1) the inherently low power of GWAS analyses
at modest sample sizes to detect genetic association signals,
FIGURE 2. Diagram of overrepresented biological processes in syndromic myopia and the associated genes.
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and (2) the sparse genotype density of the 23andMe GWAS
dataset, which provided very limited scope for VEGAS to
harness multiple, independent signals from within the vicinity
of individual genes. Had we been able to obtain access to the
full set of GWAS summary statistics for the 23andMe study, as
was the case for the CREAM study, we anticipate that the
concordance of our VEGAS findings using the two datasets
would have been higher (since there was high concordance for
the 23andMe and CREAM GWAS analyses themselves: 16 of the
20 loci identified by 23andMe were confirmed by CREAM, and
14 of the 22 loci identified by CREAM were replicated by
23andMe15).
The clinical syndromes associated with the genes identified
within this paper as having potential relevance for myopia are
listed in Table 6. Mutations that cause rare disease syndromes
tend to be rare themselves, because natural selection reduces
the likelihood of their spread through the population. Such
mutations usually affect the coding region of genes, resulting,
for example, in errors of splicing or protein truncation,33 and
therefore act deterministically to cause severe effects, irre-
spective of other genetic or environmental influences. By
contrast, mutations/polymorphisms that lead to subtle pheno-
typic changes can become common in the population and
most often affect noncoding, regulatory regions, resulting in
variation in the expression level of a nearby gene.34
Nonetheless, the concept that polymorphisms in genes
associated with severe clinical syndromes might contribute
to common forms of myopia is supported by studies showing
that genes causing syndromic high myopia can also cause high
FIGURE 3. Manhattan plot (A) and QQ plot (B) showing the observed degree of association (y-axis; minus log10 of P value) in the CREAM
Consortium GWAS for the 24,554 SNPs lying within 50 kb of the 107 autosomal OMIM derived myopia genes. The two horizontal lines in (A)
indicate nominal (P¼ 0.05) and experiment-wise (P¼ 4.1E-05) level of statistical significance, respectively. The gray shaded region in (B) indicates
the 95% confidence interval in which points would lie under the null hypothesis of no enrichment for SNPs associated with refractive error.
TABLE 4. Results of the VEGAS Gene-Based Analysis
Gene Symbol VEGAS P Value
GNPTG 5.94E-04
ALDH18A1 1.58E-03
ADAMTSL4 2.39E-03
COL9A2 8.90E-03
FBN1 9.00E-03
ASXL1 1.38E-02
LTBP2 1.53E-02
POMT1 1.59E-02
TFAP2A 1.70E-02
OCA2 1.91E-02
AGK 2.12E-02
ZNF469 2.38E-02
GJA1 2.39E-02
POLR3B 2.52E-02
IFIH1 2.55E-02
PTPN11 2.70E-02
ADAMTS18 3.88E-02
P values from the CREAM Consortium GWAS meta-analysis for
refractive error for 24,554 SNPs within 50 kb of the 107 autosomal
OMIM derived myopia genes were submitted for VEGAS gene-based
analysis. VEGAS returned scores for all 107 genes. The Table lists the 17
syndromic myopia genes associated with refractive error within the
CREAM Data, in ascending order of VEGAS P value.
FIGURE 4. QQ plot for genes examined by VEGAS. The observed
degree of association (y-axis; minus log10 of P value) in the VEGAS
analysis for 107 autosomal OMIM derived myopia genes. The gray
shaded region in the QQ plot indicates the 95% confidence interval in
which points would lie under the null hypothesis of no enrichment
within genes for SNPs associated with refractive error.
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myopia as the sole clinical feature, for example, NYX35 and
GRM6.36 That genes linked to severe phenotypes can be
associated with common myopia has also been shown by the
CREAM study. Table 7 lists the clinical syndromes from the
OMIM database that are caused by genes for refractive error
and myopia identified in the CREAM study. A total of 13 of the
28 genes identified by the CREAM and 23andMe studies are
also known to cause defined, often severe, clinical syndromes
affecting the eye and different organs. These data demonstrate
that polymorphisms within the same gene can create both mild
phenotypic variations in refractive error and severe clinical
syndromes affecting the eye and other organs.
Identification of Genetic Pathways Involved in the
Etiology of Myopia
By their very nature, GWAS cannot determine whether a
particular gene has a causal role in the condition being studied.
Instead, when a genetic locus is identified by GWAS analysis,
there may be one or more causative genes nearby, for example,
within 100 kb. Often, the risk-determining polymorphism has a
regulatory influence on the expression of one or more nearby
genes.34 Nonetheless, for several of the genes identified by the
CREAM Consortium and 23andMe, there is supporting
evidence for a causal role in refractive error development; for
example, PRSS56 is associated with microphthalmia in humans
and reduced eye size in knockout mice.37,38 SIX6 is another
gene involved in ocular morphogenesis.39 RDH5 is involved in
retinoic acid metabolism and all-trans retinoic acid has been
identified as a potential intraocular signaling molecule in a
mammalian model of myopia.40 LAMA2 and BMP2 are involved
in ECM remodeling, and BMP2 also appears to be an important
intraocular signaling molecule for controlling eye growth.41 In
contrast, all of the OMIM syndromic genes found to be
statistically linked with myopia in the CREAM Consortium and
23andMe GWAS datasets (Tables 4, 5) have already been
determined to have a direct role in producing myopia in
humans.
The large number of genes identified from syndromic forms
of myopia and other refractive errors also provided opportu-
nity to study the biological mechanisms involved in refractive
error by looking for patterns of overrepresentation of pathways
within this set of genes. We analyzed GO terms overrepresent-
ed among OMIM syndromic ametropia and myopia genes
(Tables 2, 3) to gain insight into underlying biological
processes. GO terms are used to annotate sequences, genes,
or gene products in biological databases, and represent a
controlled vocabulary designed to facilitate the integration of
information across species and biological disciplines. Although
OMIM is not one of the databases directly contributing to the
GO project, it is conceivable that researchers developing
databases that do contribute to the GO project have utilized
OMIM in their own work. This could potentially have led to
some circularity in our pathway analysis, whereby one
biological database (e.g., OMIM) is used to harness information
from another database (e.g., the GO database). However, since
OMIM is not a direct contributor to the GO project, we
consider that any circularity would have little impact on the
majority of our findings.
Many of the identified pathways (as shown in Fig. 2 and
Tables 2, 3), such as connective tissue composition and ocular
TABLE 5. OMIM Syndromic Myopia Genes Showing Enrichment of
Highly Associated Genetic Variants in the 23andMe GWAS for Age of
Onset of Myopia
Gene Symbol 23andMe GWAS P Value
KIF11 1.40E-05
COL4A1 1.60E-05
ERBB3 4.60E-05
SLC39A5 6.40E-05
ADAMTS2 7.00E-05
For genes with more than one genetic variant with a P value below
1.0E-04, only P values for the most strongly associated variant are
shown.
TABLE 6. Syndromic Myopia Genes Linked to GWAS Analysis
Gene Locus Clinical Syndrome
ADAMTS18 16q23.1 Microcornea, myopic chorioretinal atrophy, and telecanthus
ADAMTS2 5q35.3 Ehlers-Danlos syndrome, type VII, autosomal recessive
ADAMTSL4 1q21.3 Ectopia lentis et pupillae
AGK 7q34 Sengers syndrome
ALDH18A1 10q24.1 Cutis laxa, autosomal recessive, type IIIa
ASXL1 20q11.21 Bohring-Opitz syndrome
COL4A1 13q34 Brain small vessel disease with or without ocular anomalies
COL9A2 1p34.2 Stickler syndrome, type V
ERBB3 12q13.2 Lethal congenital contracture syndrome 2
FBN1 15q21.1 Marfan syndrome
FBN1 15q21.1 Weill-Marchesani syndrome 2
GJA1 6q22.31 Oculodentodigital dysplasia, autosomal recessive
GNPTAB 12q23.2 Mucolipidosis III alpha/beta
IFIH1 2q24.2 Singleton-Merten syndrome 1
KIF11 10q23.33 Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation
LTBP2 14q24.3 Microspherophakia and/or megalocornea, with ectopia lentis or without secondary glaucoma
OCA2 15q12-q13 Albinism, oculocutaneous, type II
POLR3B 12q23.3 Leukodystrophy-8, hypomyelinating, with or without oligodontia and/or hypogonadotropic hypogonadism
POMT1 9q34.13 Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1
POMT1 9q34.13 Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 1
PTPN11 12q24.13 Noonan syndrome 1
SLC39A5 12q13.3 Myopia 24, autosomal dominant
TFAP2A 6p24.3 Branchio-oculo-facial syndrome
ZNF469 16q24.2 Brittle cornea syndrome 1
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morphogenesis fit with prior hypotheses related to myopia
development.42,43 Indeed, for the pathway analysis using
REACTOME, all of the enriched pathways—namely, PDGF
signaling, axon guidance, and integrin cell surface interac-
tions—have already been implicated in myopia pathogene-
sis.17,44–49 Using other bioinformatics tools (PANTHER), several
additional novel pathways were identified as being very
overrepresented, including protein glycosylation, protein
mannosylation, lens development, gliogenesis, and Schwann
cell differentiation. This form of analysis also identified well-
recognized pathways that may be involved in myopia
development, such as those affecting collagen metabolism
and other ECM components.
The largest OMIM analysis group related to genes linked to
myopia (119 out of 154 ametropia genes). Thus the ametropia
analysis is heavily weighted toward myopia, and there is
considerable overlap in the biological processes that reached
statistical significance when comparing myopia and all forms of
refractive error. It is therefore doubtful that we can reliably
distinguish pathways relating to ametropia per se from myopia.
Nonetheless, in relation to whether the observed enrichment
patterns in hyperopia and myopia make biological sense, the
hyperopia-related genes showed a very different pattern of
process enrichment from myopia-related genes, with emphasis
on processes involved in early growth and organogenesis. This
mirrors a fundamental difference between hyperopia and myopia
in that hyperopia in adults usually represents a persistence of a
refractive error that has existed since infancy, as compared to
myopia, which, in the vast majority of cases, is acquired during
childhood and early adult years. The smaller number of pathways
found for hyperopia, as compared to myopia, is most likely to be
the result of the smaller number of genes available for analysis. A
sensitivity analysis of random subsamples of 46 out of the 119
myopes (to match the number of hyperopia-associated genes)
showed a mean number of significant processes (P < 0.05 and
>103 enrichment) reduced to 8.8 as compared to 22 with the
full set of myopia genes (n¼ 119).
There are some identifiable, albeit speculative, links
between these novel pathways and ocular development.
Glycosylation and mannosylation are processes whereby
macromolecules, such as proteins, are modified by the addition
of simple sugars (glucose or mannose). In relation to
glycosylation, high glucose levels in diabetes appear to
promote myopia, perhaps by disrupting such pathways by
nonenzymatic glycosylation.50 Primary glycosylation deficits
(such as congenital disorder of glycosylation type Ia) cause
significant brain dysfunction as well myopia, suggesting that a
neuronal pathway may be involved.51 A similar association is
seen with deficits in O-mannosylation, as demonstrated in
Walker-Warburg syndrome (OMIM phenotype 253280). While
the link with myopia remains unexplained, mannosylation is
important for cell–matrix interactions and communication and
therefore has a plausible role in the process by which neural
elements within the eye influence the growth of its connective
tissue components, including the sclera.52
There is experimental evidence that lens plays a role in eye
growth. Experimental lensectomy in infant monkeys has been
demonstrated to slow eye growth in monkeys less than 7.5
months of age, but not in older animals.53 It is therefore
possible that genes influencing lens development may have an
impact on early ocular growth and hence final refraction.
Changes in lens thickness during later childhood have also
been proposed to be an important factor in the development of
myopia.54 Glial cells have received relatively little attention in
relation to the development of refractive errors, but certainly
merit more detailed attention. One of the CREAM-identified
myopia risk genes (PRSS56) has recently been found to be
expressed in retinal Mu¨ller cells and to have a role in refractive
error development in mice (Paylakhi S, et al. IOVS 2017;58:AR-
VO E-Abstract 5635). Abnormal glial cell–derived myelination
of retinal ganglion cells (i.e., myelinated retinal nerve fibers) is
also associated with myopia development, though the mech-
anisms remain unexplained.55 Finally, within the eye Schwann
cells are associated with the intrinsic neurons of the choroid,56
a structure implicated in ocular growth regulation.
Compared to studies of the genetic basis of myopia,
hyperopia has received far less attention. A smaller number
of syndromic hyperopia genes were identified in this analysis,
but they were linked to different biological processes,
principally involved in organogenesis. This fits in with the
general clinical picture that most hyperopia is congenital and
most myopia develops during postnatal growth.
Role of X-Linked Genes
A significant number of genes associated with myopia were
found on the X chromosome, which was not included in the
CREAM and 23andMe analysis. Polymorphisms in the cone
photopigment genes, which are located on the X chromosome,
have been suggested as a cause for myopia.57 Might some
GWAS studies have missed very important myopia-predispos-
ing genes by excluding the X chromosome? The lack of any
consistent differences in the prevalence in myopia between
the sexes in adults makes this unlikely, as do the findings of a
recently reported GWAS for myopia that did include the X
chromosome.19 Nevertheless, the existence of X-linked forms
of syndromic myopia does suggest that X-linked genes may
have a role.
TABLE 7. Clinical Syndromes Associated With Myopia Genes Identified by the CREAM Study
Gene SNP Locus Clinical Syndrome
PRSS56 rs1656404 2q37.1 Microphthalmia, isolated 6
CHRNG rs1881492 2q37.1 Escobar syndrome
CACNA1D rs14165 3p14.3 Primary aldosteronism, seizures, and neurologic abnormalities
LAMA2 rs12205363 6q22.3 Muscular dystrophy, congenital merosin-deficient
CHD7 rs4237036 8q12.2 CHARGE syndrome
BICC1 rs7084402 10q21.1 Renal dysplasia, cystic, susceptibility to
RDH5 rs3138144 12q13.2 Fundus albipunctatus
PCCA rs2184971 13q32.3 Propionicacidemia
ZIC2 rs8000973 13q32.3 Holoprosencephaly-5
KCNJ2 rs4793501 17q24.3 Andersen syndrome
TJP2 rs11145465 9q21.11 Cholestasis, progressive familial intrahepatic 4
SIX6 rs1254319 14q23.1 Optic disc anomalies with retinal and/or macular dystrophy
BMP2 rs235770 20p12.3 Brachydactyly, type A2
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CONCLUSIONS
In the present study, we screened polymorphisms located in
and around genes known to cause rare genetic syndromes
featuring myopia and found them to be overrepresented in
GWAS studies of refractive error and myopia. This implies that
while rare pathogenic mutations in these genes have profound,
deterministic effects on the eye, more benign polymorphisms
in and around these same genes may have subtle effects on
ocular development and refractive error. Our identification of
21 novel genes (ADAMTS18, ADAMTS2, ADAMTSL4, AGK,
ALDH18A1, ASXL1, COL4A1, COL9A2, ERBB3, FBN1, GJA1,
GNPTG, IFIH1, KIF11, LTBP2, OCA2, POLR3B, POMT1,
PTPN11, TFAP2A, ZNF469) and several novel pathways
(mannosylation, glycosylation, lens development, gliogenesis,
and Schwann cell differentiation) potentially involved in
myopia is another small step toward explaining the missing
heritability in refractive error.2,21 In contrast to myopia,
hyperopia was found to be linked to a different pattern of
biological processes, mostly related to organogenesis. Together
with future efforts to increase the size and scale of GWAS
projects, these discoveries will improve the ability to identify
children most at risk of developing myopia for early treatment
intervention.58,59
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